Successful Use of Dupilumab in Bullous Pemphigoid: A Series of 3 Cases in Mexico
This review explores three recent case reports detailing the successful treatment of bullous pemphigoid (BP) with Dupilumab, a monoclonal antibody targeting interleukin-4 receptor alpha subunit (IL-4Rα). Each case highlights unique clinical presentations, treatment approaches, and outcomes, underscoring Dupilumab's potential as a therapeutic option in BP management.
Institutions
- Universidad Nacional Autónoma de México (MX)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-03-01
- DOI
- https://doi.org/10.5281/zenodo.14958236
- Primary Topic
- Rock Mechanics and Modeling
- Type
- article
- Field-Weighted Citation Impact
- 0.00